Mayo Clinic: Kidney Diseases trials

The registry lists 18 Kidney Diseases studies with Mayo Clinic as lead sponsor. 1 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 4Phase 2 3Phase 3 4Phase 4 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)RecruitingNCT06752577
• Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionCompletedNCT02282930Phase 3Results posted
• Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
• MEmbranous Nephropathy Trial Of RituximabCompletedNCT01180036Phase 2/3Results posted
• Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal FunctionTerminatedNCT00586261Not applicableResults posted
• Rituximab in Progressive Immunoglobulin A (IgA) NephropathyCompletedNCT00498368Phase 4Results posted
• Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKDCompletedNCT03493802
• Hypoxia and Inflammatory Injury in Human Renovascular HypertensionCompletedNCT02266394Phase 1
• New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02250287
• MSC for Occlusive Disease of the KidneyCompletedNCT01840540Phase 1
• Aliskiren in Patients With Idiopathic Membranous NephropathyWithdrawnNCT01093781Not applicable
• Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous NephropathyCompletedNCT00805753Phase 1
• Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain StudyCompletedNCT00571909Not applicable
• Rituximab in Membranous NephropathyCompletedNCT00425217Phase 2/3
• Rituximab in the Treatment of Idiopathic Membranous NephropathyCompletedNCT00405340Early Phase 1
• The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant RecipientsCompletedNCT00275535Phase 4
• Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart FailureCompletedNCT00170183Phase 3
• Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no SteroidsCompletedNCT00170053Phase 1